Managed care and sexual dysfunction

American Journal of Managed Care

Volumn 5, Issue 1 SUPPL., 1999, Pages

  Parham, William ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

SILDENAFIL;

CONFERENCE PAPER; DRUG COST; DRUG EFFICACY; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; MALE; MALE SEXUAL DYSFUNCTION; MANAGED CARE; PRIORITY JOURNAL;

COST CONTROL; DRUG COSTS; ELIGIBILITY DETERMINATION; HEALTH CARE RATIONING; HEALTH EXPENDITURES; HUMANS; IMPOTENCE; INSURANCE COVERAGE; INSURANCE, PHARMACEUTICAL SERVICES; MALE; MANAGED CARE PROGRAMS; PIPERAZINES; UNITED STATES;

EID: 0032917622     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. Levit KR, Lazenby HC, Braden BR. National health spending trends in 1996. Health Affairs 1998;17:35-51.
2. Newcomer LN. Defining experimental therapy: A third-party payer's dilemma. N Engl J Med 1990;323:1702-1704.
3. Kahan JP, et al. Measuring the necessity of medical procedures. Med Care 1994;32:357-365.
4. North Carolina General Statutes. 1997 Cumulative Supplement. Section 58-3-200,b.
5. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA, for the Sildenafil Study Group. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998;338:1397-1404.